Cranberry for gut and metabolic health in adults with overweight or obesity
Official title: Effects of Cranberry on Gut and Metabolic Health
Run by Laval University · NCT07460856 · Data updated 2026-11-12
This study will test whether drinking a cranberry beverage can improve blood sugar control, insulin sensitivity, blood lipids, and gut microbiota in adults with overweight or obesity who have metabolic risk factors.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 25 Years to 70 Years |
| Sex | All |
| Enrollment | 73 (estimated) |
| Sponsor | Laval University Academic / other |
| Locations | 1 site (Québec, Quebec) |
| Status | Recruiting |
| Started | July 7, 2025 |
| Main results expected | December 2026 |
| Study ends | December 2026 |
| Registry record updated | March 10, 2026 |
| Trial ID | NCT07460856 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with a BMI of 25–40 kg/m2 who meet at least one metabolic criterion (elevated fasting insulin >60 pmol/L, fasting glucose 5.5–6.9 mmol/L, HbA1c 5.7–6.4%, or fasting triglycerides >1.35 mmol/L) and who are not taking medications or supplements that affect study outcomes are ideal candidates.
✕Probably not a fit
People taking antidiabetic or cholesterol‑lowering medications, those with recent bariatric surgery or major surgery, regular probiotic or polyphenol supplement users, heavy alcohol consumers, or anyone with cranberry aversion are unlikely to be eligible or to derive benefit in this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, double-blind, placebo-controlled crossover trial will enroll overweight and obese adults with metabolic risk factors and have each participant consume a cranberry beverage and a matched placebo for two 12-week periods separated by a 4-week washout. Primary outcomes include measures of glucose metabolism and insulin sensitivity, blood lipid concentrations, and analyses of gut microbiota composition and function, along with markers of intestinal integrity. Participants will be randomized to the order of interventions and both participants and study staff will be blinded to beverage assignment. Key exclusions include use of antidiabetic or lipid‑lowering medications, recent major surgery or bariatric procedures, regular probiotic or polyphenol supplement use, excessive alcohol intake, and cranberry aversion.
Why it matters
Potential benefit: If successful, cranberry supplementation could improve glucose control, insulin sensitivity, and lipid profiles while favorably shifting the gut microbiota, potentially lowering cardiometabolic risk.
How similar studies have gone: Previous studies of berries and polyphenol-rich foods have shown modest improvements in metabolic markers and shifts in gut microbiota, but long-term randomized crossover trials specifically testing cranberry beverages in humans remain limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * body mass index between 25 and 40 kg/m2 * at least one of the following criteria: fasting plasma insulin \>60 pmol/L, fasting glycemia between 5.5 and 6.9 mmol/L, glycated hemoglobin (HbA1c) level of 5.7- 6.4% and/or fasting triglyceride \>1.35 mmol/L. Exclusion Criteria: * to have aversion to cranberry products * regularly drinking alcohol (\>2 glasses/day) * having a significant change in body weight in the past 3 months (±5% of their body weight) due to bariatric surgery or other conditions * taking medication which may affect the study outcomes (i.e. antidiabetic and/or cholesterol or lipid-lowering medications and/or glucocorticosteroid in supraphysiological doses and/or anti-obesity medications) * taking regular probiotics and prebiotics (including fruit/berry polyphenol supplements) in the past 3 months * having eating disorders * had undergone major surgery 3 months prior to the study or if they had one planned * if they had intestinal malabsorption, cirrhosis or chronic kidney disease * being pregnant, planning a pregnancy, or breastfeeding.
Where it's running
-
INAF, Université Laval
Québec, Quebec, Canada Recruiting
Study contacts
- Study coordinator: Julie Marois, M.Sc.
- Email: julie.marois@fsaa.ulaval.ca
- Phone: 1-418-656-5258
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Inulin Prebiotic for Perimenopausal Women with Overweight or Obesity
This study tests whether 2 weeks of inulin can affect gut and vaginal microbes, heart health, and muscle health in perimenopausal women who are overweight or obese, using a crossover design.
-
Kodo Millet Porridge and Gut Health in Overweight and Obese Adults
This study tests whether daily intake of Kodo millet porridge for 12 weeks can improve gut bacteria and metabolic health in adults who are overweight or obese.
-
MOTS-c to improve insulin sensitivity in adults with prediabetes and overweight or obesity
This 12-week test will see if the investigational peptide MOTS-c can improve insulin sensitivity in adults with prediabetes who are overweight or have obesity.
-
Photoacoustic and ultrasound imaging of brown fat activity
This project will test a radiation-free photoacoustic and ultrasound scan to see if it can measure brown fat activity in healthy adults and people with metabolic syndrome.
-
Investigating fasting insulin and insulin resistance across different demographics
This study looks at how fasting insulin levels and insulin resistance vary among different groups of people based on age, sex, race, weight, and conditions like PCOS to better understand metabolic health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.